— Know what they know.
Not Investment Advice

ORGS OTC

Orgenesis Inc.
1W: +16.0% 1M: +65.7% 3M: +45.0% YTD: +286.7% 1Y: -26.6% 3Y: -90.7% 5Y: -98.8%
$0.58
+0.03 (+5.45%)
 
Weekly Expected Move ±739.3%
$-8 $-4 $1 $5 $9
OTC · Healthcare · Biotechnology · Tech Score Buy · Power 67 · $5.7M mcap · 7M float · 0.0071% daily turnover · Short 76% of daily vol

📊 Key Metrics

TTM
$-13M
Revenue
-192.0% YoY
$-44M
Net Income
+12.1% YoY
$-16M
Free Cash Flow
+51.6% YoY
-68.6%
Gross Margin
-2419.0%
Op. Margin
2628.2%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE764.3%
ROA-117.2%
ROIC1083.0%

Valuation

P/E-0.3
P/B-0.8
EV/EBITDA-3.3

Leverage

Debt/Equity-0.72
Current Ratio0.07
Interest Cov.-23.3x

Quality Scores

Piotroski F1/9
Altman Z-16.86
Beneish M-6.26

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms